| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Bexarotene | CTRPv2 | pan-cancer | AAC | 0.03 | 0.4 |
| mRNA | Crizotinib | gCSI | pan-cancer | AAC | -0.046 | 0.4 |
| mRNA | XL765 | CTRPv2 | pan-cancer | AAC | -0.031 | 0.4 |
| mRNA | BRD-K27986637 | CTRPv2 | pan-cancer | AAC | -0.06 | 0.4 |
| mRNA | sitagliptin | CTRPv2 | pan-cancer | AAC | -0.06 | 0.4 |
| mRNA | BRD-K48334597 | CTRPv2 | pan-cancer | AAC | -0.055 | 0.4 |
| mRNA | YM-155 | CTRPv2 | pan-cancer | AAC | 0.031 | 0.4 |
| mRNA | methylstat | CTRPv2 | pan-cancer | AAC | 0.035 | 0.4 |
| mRNA | GDC-0941 | CTRPv2 | pan-cancer | AAC | -0.03 | 0.4 |
| mRNA | pac-1 | CTRPv2 | pan-cancer | AAC | -0.029 | 0.4 |